Precision Solutions

• 
  Therapeutic Antibodies and Derivatives — ADCs, BsAbs, Immunocytokines, Nanobodies

  Comprehensive overview of therapeutic antibody derivatives: ADCs (10 FDA-approved, 80+ in clinical trials), ARCs (antibody-oligonucleotide conjugates), bispecific/multispecific antibodies (BiTE, CrossMab, Knobs-into-Holes), immunocytokines (IL-2, IL-12, TGF-β trap fusions), and antibody fragments (Fab, scFv, VHH nanobodies, DARPins). Covers mechanisms, approved products, and future directions including TCR-mimic antibodies for intracellular antigen targeting.